The cytotoxic activity of cisplatin, carboplatin and teniposide alone and combined determined on four human small cell lung cancer cell lines by the clonogenic assay

European Journal of Cancer and Clinical Oncology - Tập 24 - Trang 247-253 - 1988
Henrik Roed1, Lars L. Vindeløv2, IB J. Christensen3, Mogens Spang-Thomsen4, Heine Høi Hansen1
1Department of Oncology B, Finsen Institute, University of Copenhagen, Denmark
2Department of Internal Medicine, Finsen Institute, University of Copenhagen, Denmark
3The Finsen Laboratory, Finsen Institute, University of Copenhagen, Denmark
4University Institute of Pathological Anatomy, University of Copenhagen, Denmark

Tài liệu tham khảo

Roed, 1987, Inter-experiment variation and dependence on culture conditions in assaying chemosensitivity of human small cell lung cancer lines, Eur J Cancer Clin Oncol, 23, 177, 10.1016/0277-5379(87)90012-5

Roed, 1987, The effect of the two epipodophyllotoxin derivatives etoposide (VP-16) and teniposide (VM-26) on cell lines established from patients with small cell carcinoma of the lung, Cancer Chemother Pharmacol, 19, 16, 10.1007/BF00296248

Roed, 1987, In vitro evaluation of a new nitrosourea, TCNU, against human small cell lung cancer cell lines, Cancer Chemother Pharmacol, 19, 315, 10.1007/BF00261480

Selby, 1983, A critical appaisal of the ‘human tumor stem-cell assay’, N Engl J Med, 308, 129, 10.1056/NEJM198301203080304

Burchenal, 1978, Studies of cross-resistance, synergistic combinations and blocking of activity of platinum derivatives, Biochimie, 60, 961, 10.1016/S0300-9084(78)80582-3

Wilkinson, 1978, Selection of potential second generation platinum compounds, Biochimie, 60, 851, 10.1016/S0300-9084(78)80569-0

Calvert, 1982, Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II, Cancer Chemother Pharmacol, 9, 140, 10.1007/BF00257742

Evans, 1984, VP-16 alone and in combination with cisplatin in previously treated patients with small cell lung cancer, Cancer, 53, 1461, 10.1002/1097-0142(19840401)53:7<1461::AID-CNCR2820530706>3.0.CO;2-N

Vindeløv, 1983, A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis, Cytometry, 3, 323, 10.1002/cyto.990030503

1983

Curt, 1983, A phase I and pharmacokinetic study of diamminecyclobutanedecarboxylatoplatinum (NSC 241240), Cancer Res, 43, 4470

Alberts, 1980, Tabular summary of pharmacokinetic parameters relevant to in vitro drug assay, 351

Micetich, 1985, A comparison of the cytotoxicity and DNA damaging effects of cis-(diammino) (1,1-cyclobutanedicarboxylato)-platinum (II) (CBDCA) and cis-diamminodichloroplatinum (II) (DDP) on L 1210 cells, 26, 1037

Himmelstein, 1981, Clinical kinetics of intact cisplatin and some related species, Clin Pharmacol Ther, 29, 658, 10.1038/clpt.1981.91

Schabel, 1979, Cis-dichlorodiammineplatinum (11): combination chemotherapy and cross-resistance studies with tumors of mice, Cancer Treat Rep, 63, 1459

Valeriote, 1975, Synergistic interaction of anticancer agents: a cellular perspective, Cancer Chemother Rep Part 1, 59, 895

Pedersen, 1983, Etoposide (VP-16) in the treatment of lung cancer, Cancer Treat Rev, 10, 245, 10.1016/0305-7372(83)90013-0

Porter, 1985, Cisplatin and etoposide combination chemotherapy for refractory small cell carcinoma of the lung, Cancer Treat Rep, 69, 479

Gupta, 1983, Genetic, biochemical and cross-resistance studies with mutants of Chinese hamster ovary cells resistant to anticancer drugs, VM-26 and VP-16–213, Cancer Res, 43, 1568

Drewinko, 1976, Combination chemotherapy in vitro with cis-dichlorodiammineplatinum (11), Cancer Treat Rep, 60, 1619

Steel, 1979, Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity, Int J Radiat Oncol Biol Phys, 5, 85, 10.1016/0360-3016(79)90044-0

Thông tin
Thông tin xuất bản

European Journal of Cancer and Clinical Oncology

Tập 24

247-253

Thông tin tác giả